ChemoCentryx
CCXI
$51.99
Share price
0.00%
Change (1 day)
33.72%
Change (1 year)
Categories
EPS for ChemoCentryx (CCXI)
EPS in 2022 (TTM): -$1.89
According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -$1.89. In 2021 the company made an earnings per share (EPS) of -$1.89 a decrease over its 2020 EPS that were of -$0.81.
EPS history for ChemoCentryx from 2012 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -$1.89 | -0% |
| 2021 | -$1.89 | 133.33% |
| 2020 | -$0.81 | -16.49% |
| 2019 | -$0.97 | 27.63% |
| 2018 | -$0.76 | -305.41% |
| 2017 | $0.37 | -142.53% |
| 2016 | -$0.87 | -19.44% |
| 2015 | -$1.08 | -0% |
| 2014 | -$1.08 | 13.68% |
| 2013 | -$0.95 | -16.67% |
| 2012 | -$1.14 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -845.25% | 🇺🇸 USA |
 Pfizer PFE | $1.86 | -198.41% | 🇺🇸 USA |
 AbbVie ABBV | $3.68 | -294.74% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | -848.68% | 🇺🇸 USA |
 Biogen BIIB | $18.46 | -1,076.72% | 🇺🇸 USA |
 Merck MRK | $1.82 | -196.39% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | -310.05% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -285.22% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$2.00 | 5.82% | 🇮🇱 Israel |